🇺🇸 FDA
Pipeline program

Allogeneic MSC

2020-0334

Phase 1 mab completed

Quick answer

Allogeneic MSC for Mesenchymal Stromal Cells is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Mesenchymal Stromal Cells
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials